#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nodal marginal zone B-cell lymphoma Acute myeloid leukaemia recurrent Osteochondrodysplasia Subdural haematoma Friedreich's ataxia Obliterative bronchiolitis Tuberous sclerosis complex Intracranial calcification Optic glioma Atypical haemolytic uraemic syndrome Stevens-Johnson syndrome Microscopic polyangiitis Pancreatic neuroendocrine tumour Partial lipodystrophy Pseudoxanthoma elasticum More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Diagnostics Adrenocortical carcinoma – Trials in Disease Piriformis syndrome – Trials in Disease Haemophilia A without inhibitors Lysosomal storage disorder – Trials in Disease Breast angiosarcoma metastatic Bronchiolitis obliterans syndrome – Trials in Disease Mantle cell lymphoma stage II – Treatment CADASIL – Diagnostics Fragile X syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Grwd5769 Nifedipine Thymalfasin Obeticholic Acid Zibotentan Elvn-002-1 Triptorelin Pamoate Adrc Netupitant ABIRATERONE DECANOATE Eptinezumab Pevonedistat ATTR-01 Tilmanocept Buspirone Hydrochloride Azenosertib Holcus Lanatus Pollen Extract Rp1 Wt1 Mrna Dc Prilocaine More therapies…

    Learn about Your Condition

    Richter's syndrome Gallbladder cancer Tertiary adrenal insufficiency Thrombosis prophylaxis Coronary artery dissection Malignant melanoma stage III Fungal infection Lung disorder Pemphigus Hand dermatitis Undifferentiated sarcoma Peptostreptococcus infection Seasonal allergy Pigmentary glaucoma Biliary tract disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    • Splenic marginal zone lymphoma
    • Nodal marginal zone B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    Germany

  • Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Dexmedetomidine
    Norway

  • Feasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    The Netherlands

  • Safety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    • Tofacitinib
    • Upadacitinib
    France

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    • Sodium Chloride
    France Germany Italy Luxembourg Spain Sweden

  • Switch maintenance with paclitaxel, ramucirumab and tislelizumab versus continued chemotherapy with tislelizumab in HER2‑negative, PD‑L1‑positive gastroesophageal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Ramucirumab
    • Calcium Folinate
    • Cisplatin
    Germany Italy Spain
Previous Page
1 … 692 693 694 695 696 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!